HilleVax
Social media
HilleVax Logo
About HilleVax
HilleVax Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. Its lead candidate, HIL-214, is a virus-like particle-based vaccine targeting the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company operates in the United States.
Address
321 Harrison Avenue, 5th floor
Boston, 02118
United States
Year founded
2020
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
